Imstar

IMSTAR is present at the 6th International Conference on Enviromental Mutagens in Human Populations ICEMHP, Doha, Qatar, on 25-29 March 2012

Fri, 23 Mar 2012 12:56:56 +0100

On March 26th, 2012, Dr Françoise SOUSSALINE, President&CEO, is invited speaker to the panel of the preconference “HUMN/HUMNxl Automated Micronucleus Workshop Using Image Cytometry Systems”

On the 6th International Conference on Environmental Mutagens in the Human Population a poster will be displayed: "Automated image analysis of the micronucleus cytome assay and comet assay for high throughput human biomonitoring and in vitro/in vivo genotoxicity testing in industry studies: IMSTAR system." F. Soussaline (1), A. Papine (1), E. Tatarinova (1), I. Decordier (2), J. Dumont (3), A. Azqueta-Oscoz (4), A.K. Sharma (5), M-L. Binderup (5), A. Collins (4) , E. Lorge (3), M. Kirsch-Volders (2)
Read Abtract

During the conference, IMSTAR demonstrates its Pathfinder™ technology at Booth 8 in the exhibition are

On March 8th, 2011 Paris Region Innovation Center web site published an article about Françoise Soussaline

Tue, 08 Mar 2011 11:09:35 +0100

On March 8th, 2011 Paris Region Innovation Center web site published an article about Françoise Soussaline, President & CEO IMSTAR S.A., entitled: “Beautiful stories March 2011 - Innovations: female plural”. The article honours a certain number of women having created an innovating company.

For more information is available on the 'Centre Francilien de l'Innovation' website: http://www.innovation-idf.org/fr/les-belles-histoires/mars-2011innovations-feminin-pluriel

Automated image analysis of micronuclei by IMSTAR for biomonitoring

Mon, 17 Jan 2011 16:25:33 +0100

Ilse Decordier, Alexandre Papine, Kim Vande Loock, Gina Plas, Françoise Soussaline and Micheline Kirsch-Volders. ‘Automated image analysis of micronuclei by IMSTAR for biomonitoring’ Article published in Special issue of Mutagenesis vol. 26 no. 1 pp. 163–168, 2011.
We are very proud of the international recognition of our IMSTAR Pathfinder micronuclei automated system as an accurate, versatile, reliable and competitive solution available today on the market.

Read Article

Imstar to present at Shanghai World Expo 2010

Sat, 18 Sep 2010 13:33:37 +0100

September 24th – 25th, 2010. Dr. Françoise SOUSSALINE, IMSTAR President & CEO, will present at the Shanghai World Expo 2010 the company realizations as an active member of MEDICEN Paris Region Biocluster, in the context of the Research-Innovation week taking place at the French Ile-de-France Pavilion.

Françoise Soussaline, awarded 2010 Irène Joliot-Curie Prize by French Minister of Higher Education and Research, Valerie Pecresse

Mon, 21 Jun 2010 19:07:50 +0100

This award highlights and encourages a woman who has distinguished herself through exemplary scientific activity within the field of French research.

More information is available on the Ministry of Higher Education and Research' website: http://www.enseignementsup-recherche.gouv.fr/cid52213/remise-du-prix-irene-joliot-curie-2010.html

PathFinder™ Cellscan System installed at Centre of Toxicology, University of London

Mon, 14 Jun 2010 18:44:32 +0100

IMSTAR recently installed the PathFinder™ Cellscan MN platform for automated micronucleus assay scoring at the Centre of Toxicology, School of Pharmacy at University of London. Professor Andreas Kortenkamp is Head of Centre.
The research at the centre for Toxicology is focused on three areas: the combination effects of mixtures of environmental pollutants with endocrine-disrupting properties; anti-tumour agents and novel drug carrier systems; and organ toxicity. There is a current focus on endocrine active chemicals in the environment and particularly the effects of multi-component mixtures. The joint effect of mixtures is also being studied in relation to the optimisation of anti-cancer combination therapy. Research is also being undertaken to assess the adverse effects of drugs and chemicals on organs including the heart, kidney, liver, musculo-skeletal system and lymphoid organs.

The Pathfinder™ Cellscan MN automated System will be used, essentially, in the last research area.

For more information see http://www.lon.ac.uk

Poster presented at Society of Toxicology’s 49th annual meeting and ToxExpoT 2010, Salt Lake City, Utah, USA, March 7-11, 2010

Thu, 11 Mar 2010 17:25:45 +0100

Gladys Ouedraogo, from L’Oreal International Safely Research Department, presented results of a collaboration work between IMSTAR’ team entitled: “ Towards an automated scoring system for the Syrian hamster embryo assay”

Read Abstract

Paris - 8th March 2010. Françoise Soussaline, IMSTAR President, awarded the 2010 Irène Joliot-Curie Prize.

Mon, 08 Mar 2010 11:17:47 +0100

The jury, chaired by Françoise Barré-Sinoussi, Nobel Prize of Medicine 2008, awarded Françoise Soussaline the prize in the "Top female scientific company career" category, to reward a woman who has dedicated her remarkable scientific and technical skills to a career in research within a company or who has contributed to the creation of an innovative firm.
This award highlights and encourages a woman who has distinguished herself through exemplary scientific activity within the field of French research. Françoise Soussaline will be awarded her prize in June 2010 by Valérie Pecresse, the Minister for Higher Education and Research.
More information is available on the Ministry of Higher Education and Research' website: http://www.enseignementsup-recherche.gouv.fr/cid50774/les-laureates-du-9e-prix-irene-joliot-curie.htm

Françoise Soussaline is a PhD in Molecular Spectroscopy and D.Sc in Biophysics under the guidance of Pr Georges Charpak, Physics Nobel Prize. Trained in Paris, France and in the USA, she was Assistant Professor at Paris Medical Faculty, Researcher at the National Institute of Health and Medical Research (Pr Maurice Tubiana), and Head of the Instrumentation and Biomedical Sciences Group at the Atomic Energy Commission for the design and development of PET (Pr André Syrota). Françoise founded IMSTAR in 1985, incorporated in 1990, and since then, she is the President and Chief Scientific Officer. IMSTAR is a high tech company specialized in the design, development and marketing of Automated Cellular Imaging Systems based on Pathfinder™ patented technology for Genetic toxicology, Cytogenetics and Cyto-Pathology in research and assisted diagnostic, as well as tumor cells detection and therapeutic staging. IMSTAR is an active partner or project leader of several EU and French consortia.
Since 2006, she is a representative of innovative SMEs as member of the executive board of Medicen Paris Region Biocluster, for innovation and technology transfer in Biomedical business and promotion of Health advanced technologies at the European Commission level.
She was awarded by the Ministry of Industry, in 1997, Chevalier de la Légion d’Honneur for her contribution to Bio-medical innovation in Industrial research.

Contact: francoise.soussaline@imstarsa.com

Conference presented at TOPIM 2010 (for ‘hot TOPics in molecular IMaging) workshop, organized by the European Society for Molecular Imaging (ESMI) and the European Network of Excellence DiMI, Bardonecchia, Italy, February 7-12th, 2010

Fri, 12 Feb 2010 16:50:12 +0100

Results of collaboration between presented a conference entitled: “Kinome-targeted siRNA screen identifies, kinase regulating the differentiation/proliferation balance in prostate cancer cells “

Read Abstract

The 4th Annual Consortium Meeting of NewGeneris, University of Crete, Heraklion, on 3-5 February 2010.

Mon, 25 Jan 2010 13:29:59 +0100

IMSTAR will be represented at the 4th Annual Consortium meeting for NewGeneris next month in the University of Crete, Greece.
New Generis is an Integrated Project which forms part of the ‘Integrating and Strengthening the European Research Area’ program established under the European Commission Sixth Framework. The project focuses on the ‘Development and application of Biomarkers of dietary exposure to genotoxic and immunotoxic chemicals and of Biomarkers of early effects, using mother-child birth cohorts and biobanks'

For more information see http://www.newgeneris.org/

IMSTAR expends on the Tobacco Industry market

Mon, 18 Jan 2010 12:24:10 +0100

British American Tobacco, through its subsidiary Advanced Technologies Cambridge, is a long-date customer of IMSTAR for automated screening in genetic toxicology assays. Today, IMSTAR is proud to announce that the company will also supply Japan Tobacco International, through its subsidiary in Austria. IMSTAR provides cutting-edge technologies for fast and reliable automated scoring in genetic toxicology assays, including micronucleus assay in Acrinine Orange staining.

Full success for BIOTYPE project:

Wed, 13 Jan 2010 10:05:24 +0100

BIOTYPE, a project led by IMSTAR and certified in 2006 by the Pôle de Compétitivité MEDICEN of the Paris Region, has come to its term, after 30 months. It involved six innovative SMEs, Sanofi Aventis a big Pharma and four academic labs CEA, Pasteur Institute, Armines and AssitancePublique-Hôpitaux de Paris, to develop new approaches in functional cellular screening and molecular profiling in predictive and tailored medicine, using as a demonstrator the prostate cancer pathologies at different stages. After one PhD, six papers, fifteen presentations in world class conferences, but also the set-up of integrated platforms involving high-throughput and high-content multiplex phenotyping characterization, it has proved to be fully sucessful in paving the way to clinical applications.

Poster presented at Conference on Functional Genomics and Systems Biology Workshop, Welcome Trust, Cambridge, UK, November 30th-December 2nd, 2009

Wed, 02 Dec 2009 13:47:54 +0100

Jean-Philippe Vert, Mines ParisTech, CBIO presented results of a collaborative work between IMSTAR’ team, CBIO & CMM Mines ParisTech’ team, Biopuces Laboratory, Atomic Energy Commission (CEA), in the frame of the french R&D Project BIOTYPE, led by IMSTAR and certified by MEDICEN PARIS REGION competitivity cluster, entitled: “ High-troughput screening of kinase inhibition effect on prostate tumour cell differentiation and proliferation“.

Read Poster

IMSTAR expands in the genotox service market in South America

Mon, 16 Nov 2009 13:10:15 +0100

IMSTAR has installed Pathfinder™ Cellscan SreenTox, a robotized system for automated screening of genetic toxicology assays including micronucleus assay, comet assay, chromosome aberrations scoring, mitotic index measurement and H2AX foci detection, at the Genotox Instituto Royal in Porto Alegre (Brazil). This prestigious center is focussed on providing service to various industries in South America while performing a cutting-edge research activity.

ICEM conference 2009 in Florence (Italy)

Mon, 17 Aug 2009 09:00:44 +0100

IMSTAR will present its newer achievements in automated imaging at the exhibition space (booth n°8) of the ICEM conference to be held in Florence (Italy) from August the 20th to the 25th 2009. On this occasion, IMSTAR will also present several scientific posters during the scientific sessions, in collaboration with prestigious european research groups. IMSTAR develops and commercializes automated imaging systems for research, in vitro diagnostic and screening. In particular, the company proposes cutting-edge instruments for fully automated scoring of in vitro and in vivo comet assay, in vitro and in vivo micronucleus assay, chromosome aberrations scoring, mitotic index measurements and H2AX expression determination.